Pcsk1n Antibody - N-terminal region
Rabbit Polyclonal Antibody
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Application
| WB |
---|---|
Primary Accession | Q9QXU9 |
Other Accession | NM_019279, NP_062152 |
Reactivity | Human, Mouse, Rat, Bovine, Guinea Pig, Dog |
Predicted | Human, Mouse, Rat, Pig, Bovine, Guinea Pig, Dog |
Host | Rabbit |
Clonality | Polyclonal |
Calculated MW | 28kDa |
Gene ID | 246333 |
---|---|
Alias Symbol | Saas |
Other Names | ProSAAS, Proprotein convertase subtilisin/kexin type 1 inhibitor, Proprotein convertase 1 inhibitor, pro-SAAS, KEP, Big SAAS, b-SAAS, Little SAAS, l-SAAS, Big PEN-LEN, b-PEN-LEN, SAAS CT(1-49), PEN, PEN-20, Little LEN, l-LEN, Big LEN, b-LEN, SAAS CT(25-40), Pcsk1n |
Format | Liquid. Purified antibody supplied in 1x PBS buffer with 0.09% (w/v) sodium azide and 2% sucrose. |
Reconstitution & Storage | Add 50 ul of distilled water. Final anti-Pcsk1n antibody concentration is 1 mg/ml in PBS buffer with 2% sucrose. For longer periods of storage, store at 20°C. Avoid repeat freeze-thaw cycles. |
Precautions | Pcsk1n Antibody - N-terminal region is for research use only and not for use in diagnostic or therapeutic procedures. |
Name | Pcsk1n |
---|---|
Function | May function in the control of the neuroendocrine secretory pathway. Proposed be a specific endogenous inhibitor of PCSK1 (PubMed:10632593, PubMed:10816562). ProSAAS and Big PEN-LEN, both containing the C-terminal inhibitory domain, but not the processed peptides reduce PCSK1 activity in the endoplasmic reticulum and Golgi. It reduces the activity of the 87 kDa form but not the autocatalytically derived 65 kDa form of PCSK1. Subsequent processing of proSAAS may eliminate the inhibition. Slows down convertase-mediated processing of proopiomelanocortin and proenkephalin. May control the intracellular timing of PCSK1 rather than its total level of activity (By similarity). |
Cellular Location | Secreted {ECO:0000250|UniProtKB:Q9QXV0}. Golgi apparatus, trans-Golgi network {ECO:0000250|UniProtKB:Q9QXV0} |
Tissue Location | Expressed in adult brain (all major structural regions), adrenal gland (medulla) and spinal cord (dorsal and ventral horn). Expressed in pancreatic islands. |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
References
Fricker L.,et al.J. Neurosci. 20:639-648(2000).
Donadel G.,et al.Neuroendocrinology 67:190-196(1998).
Qian Y.,et al.J. Biol. Chem. 275:23596-23601(2000).
Mzhavia N.,et al.Biochem. J. 361:67-76(2002).
Morgan D.J.,et al.J. Neurochem. 93:1454-1462(2005).
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.